Skip to content

Pilot Study - Auricular Vagus Nerve Stimulation Effects on Cardiovascular Parameters

Functional Mapping of Auricular Vagal Stimulation Points on Cardiovascular Parameters in Healthy Subjects - Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02139293
Enrollment
10
Registered
2014-05-15
Start date
2018-01-31
Completion date
2018-12-31
Last updated
2017-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Modulation of Cardiovascular Parameters and Sympathovagal Balance in Healthy Subjects

Keywords

vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion

Brief summary

The purpose of this pilot study is to evaluate the effect of auricular autonomous nervous system stimulation on cardiovascular parameters and sympathovagal balance in healthy subjects. It is investigated if auricular vagal nerve stimulation affects heart rate variability as well as peripheral local blood perfusion, and if this effect depends on the site of stimulation in the auricle, whereas four distinct stimulation points are tested.

Interventions

DEVICEPrimeStim

Intermittent auricular vagus nerve stimulation at different ear points

Sponsors

Vienna University of Technology
CollaboratorOTHER
Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* men and women aged 20 to 50 years

Exclusion criteria

* participation in a clinical trial in the last 5 weeks * diseases which may affect the autonomous nervous system (e.g., diabetes mellitus) * confounding medical treatment with known effects on the autonomous nervous system (e.g., beta blocker) * drug abuse * active implanted devices * pregnancy or nursing

Design outcomes

Primary

MeasureTime frameDescription
change in heart rate variability (HRV) related to stimulation site in the auriclewithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cyclesHeart rate variability will be assessed as, e.g., standard deviation in heart rate over a time window of 5 minutes (2.5 minutes overlap), total power or low to high frequency power. Changes in assessed heart rate variability parameters will be assessed and compared between subjects with respect to stimulation site using statistical tests.
change in local blood perfusion index (BPI) related to stimulation site in the auriclewithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cyclesBlood perfusion index at the foot will be assessed as peak-peak amplitude (systolic to diastolic) divided by the mean signal value of optically measured blood perfusion. Changes in mean value and standard deviation of local blood perfusion index will be assessed and compared between subjects with respect to stimulation site using statistical tests.

Secondary

MeasureTime frameDescription
Changes in respiratory activitywithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cyclesRespiratory activity is monitored using a respiratory belt.
Changes in oxygen saturation of the toewithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cycles
Changes in partial transcutaneous oxygen pressure of the forefootwithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cycles
Changes in foot skin temperaturewithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cycles
Change of local BPI in upper and lower extremitieswithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cyclesLocal BPI is assessed using optical sensors on the foot and the finger of participants. Changes in mean value of BPI are analyzed using statistical tests.
Tolerance of stimulationat each day of intervention at the stimulation cyclesTolerance of stimulation is assessed by free survey.
Perception of Stimulationat each day of intervention at the stiumulation cyclesPerception of stimulation is assessed by free survey.
Adverse effects of stimulationwithin 4 days of intervention
Changes of C reactive protein- and leukocyte-concentration in serumat screening and at the last day of intervention
Changes in blood pressurewithin 4 days of intervention, at each day of intervention from baseline to stimulation and pause cyclesBlood pressure is continuously measured using inflatable finger cuffs.

Countries

Austria

Contacts

Primary ContactJozsef C Széles, Dr.med.
jozsef.szeles@meduniwien.ac.at+4367687832013
Backup ContactStefan Kampusch, MSc
stefan.kampusch@tuwien.ac.at

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026